A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide

Tara Gurung,1 Deepson S Shyangdan,1 Joseph Paul O’Hare,2 Norman Waugh1 1Warwick Evidence, 2Division of Metabolic and Vascular Health, Warwick Medical School, University of Warwick, Coventry, UK Background: Dulaglutide is a new, long-acting glucagon-like peptide analogue in the treatment of...

Full description

Saved in:
Bibliographic Details
Main Authors: Gurung T, Shyangdan DS, O’Hare JP, Waugh N
Format: article
Language:EN
Published: Dove Medical Press 2015
Subjects:
Online Access:https://doaj.org/article/bc350032f4514bc8a491ff16d157897f
Tags: Add Tag
No Tags, Be the first to tag this record!